← Evidence map

ArticleDermatology and therapy2025

Efficacy and Safety of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel: Post Hoc Analysis by Baseline Disease Severity.

Michael Gold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

4 trials

NCT03170388phase 2741 enrolled2017 NCT04214639phase 3183 enrolled2020 NCT04214652phase 3180 enrolled2020 NCT04892706phase 2686 enrolled2021

Efficacy and Safety of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel: Post Hoc Analysis by Baseline Disease Severity. | OpenQuestion